Tilray Brands, Inc.
As of Oct 22, 2026, Tilray Brands is in Stage 4, the downtrend phase, now in week 36 (since Feb 9, 2026). It closed at $2.93, 80.3% below its 52-week high and below its 200-day average, which is falling.
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Mi… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is TLRY early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
TLRY among Drug Manufacturers - Specialty & Generic73rd of 84 by relative strength
All 84 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CPIX | Stage 2 · wk 23 | 98 | +6.8% |
| 2 | ETON | Stage 2 · wk 30 | 97 | −10.1% |
| 3 | ANIK | Stage 2 · wk 15 | 96 | +3.5% |
| 4 | IRWD | Stage 3 · wk 3 | 96 | −16.4% |
| 5 | TEVA | Stage 2 · wk 9 | 95 | +3.1% |
| 6 | AMRX | Stage 2 · wk 19 | 95 | +5.9% |
| 7 | KNSA | Stage 2 · wk 73 | 95 | +6.2% |
| 8 | AMLX | Stage 2 · wk 15 | 93 | −6.6% |
| …73 | TLRY | Stage 4 · wk 36 | 11 | −28.7% |
Tilray Brands: quick answers
What stage is Tilray Brands in?
As of Oct 22, 2026, Tilray Brands (TLRY) is in Stage 4, the downtrend phase. It entered Stage 4 on Feb 9, 2026 and is in week 36. What the four stages mean
Is Tilray Brands in an uptrend?
No. Tilray Brands is in a Stage 4 downtrend. It trades 48.3% below its 200-day average, which is falling.
How far is Tilray Brands from its 52-week high?
Tilray Brands closed at $2.93 on Oct 22, 2026, 80.3% below its 52-week high of $14.90. Its 52-week low is $2.92.
How has Tilray Brands performed over the past year?
As of Oct 22, 2026, Tilray Brands is down 80.2% over the past year and down 69.9% so far in 2026.
Which sector and industry is Tilray Brands in?
Tilray Brands is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.
About this companyHealth Care· Drug Manufacturers - Specialty & Generic
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Shock Top, Montauk Brewing, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point, Alpine, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Cruisies, Atwater Brewery, Hi-ball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.